alexa Regeneration And Repair Of Post-infarct Cardiovascular Tissues With Rejuvenated Stem Cells
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

Joint Conference:3rd International Conference & Exhibition on TISSUE PRESERVATION AND BIOBANKING & 6th International Conference onTISSUE ENGINEERING AND REGENERATIVE MEDICINE
August 23-24, 2017 San Francisco, USA

Yong-Jian Geng
University of Texas McGovern School of Medicine, USA
ScientificTracks Abstracts: J Tissue Sci Eng
DOI: 10.4172/2157-7552-C1-033
Abstract
Stem cell-based therapy has been emerging as novel treatment of various pathological conditions that routine medications are not effective to. Cardiovascular tissue regeneration and repair with different types of stem cells from adult tissues have been confirmed in both animal studies and clinical trials. However, autologous stem cell therapy has confronted a major obscle that stem cells from sick, aged patients with cardiovascular diseases are often malfunctional and have lower potency of regeneration and repair. To overcome this obscle, several approaches have been developed in this laboratory, including genetic or epigenetic rejuvenation, preconditioning with anti-atherogenic drugs, and enhancing survival and growth with cytokines and growth factors. Recent study has shown that transplantation of mesenchymal cells rejuvenated by overexpression of telomerase and myocardin, promotes revascularization and tissue repair in a murine model of ischemia. In vitro experiments further demonstrated that co-delivery of telomerase and myocardin genes rejuvenate adult stem cells to hightened myogenic development. Delivery of the iPS reprograming nuclear factor Oct3/4 improves the stem cell potential for tissue regeneration and repair. In atherosclerosis-prone mice, epigenetic modification of Oct3/4 gene promotor activity impacts the pathogenesis of atherosclerosis. Recent studies by this and other groups have documented evidence that treatment with statin, a cholesterollowering drup, augments the therapeutic efficacy of adult stem stem cells. Animal study has shown that atorvastatin enhances the efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase. Simvastatin-enhanced expression of promyogenic nuclear factors and cardiomyogenesis of murine embryonic stem cells.
Biography

Dr. Yong-Jian Geng, in 1994, received doctoral degree in clinical chemistry from Goethenburg University, Sweden, and post-doctoral training at Brigham and Women’s Hospital, Harvard Medical School. 1997-1999, he joined faculty at Allegency General Hospital, Pittsburgh, and since University of Texas Health Science Center at Houston. He was appointed as director of Center for Cardiovacular Biology and Atherosclerosis Center and laboratory of Heart Failure and Stem Cell Research, Texas Heart Institute. He is a tenured, full professor of medicine, molecular pathology and bioengineering. His research work is focused on diagnosis, prevention and treatment of atherosclerosis-associated cardiovascular diseases as well as stem cell therapy.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords